Shelby, Tennessee (TN) Commercial Medical Research Companies

Featured companies
Adept Bio
6555 Quince Road # 400
Memphis TN 38119
(901) 435-5570
Amgen Inc
1015 Fairmeadow Road
Memphis TN 38117
Institute of Laboratory Animal
9190 Crestwyn Hills Drive
Memphis TN 38125
(901) 759-7578
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Integrative Wellness & Rsrch
6262 Poplar Avenue # 200
Memphis TN 38119
(901) 763-7006
Research Strategies Inc
5395 Estate Office Drive # 2
Memphis TN 38119
(901) 685-8890
Urova Medical Inc
20 Dudley St # 804
Memphis TN 38103
(484) 356-3507

Urova Medical Inc is a privately held company in Memphis, TN and is a Single Location business.
Amgen Rodger Rod Robinson-H042
1084 Martinsburg Cove
Collierville TN 38017
(901) 853-2099
Amgen Shannon Reed H042777945
1946 Ivy Wood Cove
Collierville TN 38017
(901) 850-9789
Analysis International
475 East South St.
Collierville TN 38017
Kozmos Research Laboratories LLC
9480 Fox Hill Circle South
Germantown TN 38139
(626) 484-7036
Pharmacon Services Inc
12252 South Stately Oak Drive
Arlington TN 38002
(901) 317-7628
Whereorg has 11 results under Commercial Medical Research Companies in Shelby.

Narrow down the browsing criteria below to see more companies.

Select a location for category Commercial Medical Research


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020